{
    "code": "52026541",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026541",
    "time": "2022-08-26 03:45:15",
    "許可證字號": "衛部藥輸字第026541號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/05\/18",
    "發證日期": "104\/05\/18",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202654100",
    "中文品名": "&quot;卡比&quot;肌鬆弛注射液2毫克\/毫升",
    "英文品名": "Cisatracurium Kabi 2mg\/ml solution for injection\/infusion",
    "適應症": "本品為一高選擇性及競爭性的非去極化神經肌肉阻斷劑。可作為全身麻醉之輔助劑或加護病房使用，用以鬆弛骨骼肌，幫助氣管插管及與人工呼吸器的協調。",
    "劑型": "270注射劑",
    "包裝": "2.5毫升、5毫升、10毫升玻璃安瓿裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "CISATRACURIUM BESYLATE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "6201179728  台灣費森尤斯卡比股份有限公司",
    "申請商地址": "台北市大安區仁愛路三段30號5樓32號5樓",
    "主製造廠": [
        {
            "製造廠名稱": "FZA0012000  Fresenius Kabi Manufacturing SA (Pty) Ltd",
            "製造廠廠址": "6 GIBAUD ROAD KORSTEN PORT ELIZABETH SOUTH AFRICA",
            "製造廠公司地址": "",
            "製造廠國別": "SOUTH AFRICA",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1220002510",
            "成分名稱": "CISATRACURIUM BESYLATE",
            "含量描述": "(eq. to Cisatracurium 2mg)",
            "含量": "2.6800000000",
            "單位": "MG"
        }
    ],
    "仿單外盒": [
        {
            "title": "020265410001-104-07-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026541&Seq=001&Type=9"
        },
        {
            "title": "52026541-2-104-07-15.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026541&Seq=002&Type=8"
        }
    ]
}